chr6-10621458-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145649.5(GCNT2):c.1018+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000216 in 1,388,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145649.5 intron
Scores
Clinical Significance
Conservation
Publications
- cataract 13 with adult I phenotypeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- total early-onset cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_145649.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GCNT2 | TSL:2 MANE Select | c.1018+15C>T | intron | N/A | ENSP00000419411.2 | Q8N0V5-1 | |||
| GCNT2 | TSL:1 MANE Plus Clinical | c.1012+15C>T | intron | N/A | ENSP00000314844.3 | Q8N0V5-2 | |||
| GCNT2 | TSL:1 | c.1018+15C>T | intron | N/A | ENSP00000265012.4 | Q8N0V5-3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000404 AC: 1AN: 247644 AF XY: 0.00000747 show subpopulations
GnomAD4 exome AF: 0.00000216 AC: 3AN: 1388984Hom.: 0 Cov.: 23 AF XY: 0.00000288 AC XY: 2AN XY: 694880 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at